{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:10:05Z","timestamp":1788649805280,"version":"build-2803163510"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":64,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1255426N"],"award-info":[{"award-number":["1255426N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bpg.2025.102060","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:25:19Z","timestamp":1761697519000},"page":"102060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cutting edge developments and novel targets in IBD: Microbiome in IBD"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8596-2783","authenticated-orcid":false,"given":"Sara","family":"Deleu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpg.2025.102060_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrmicro.2017.158","article-title":"The germ-organ theory of non-communicable diseases","volume":"16","author":"Byndloss","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bpg.2025.102060_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2025.102060_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8320","article-title":"Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites","volume":"6","author":"Thorburn","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.bpg.2025.102060_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2025.102060_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","article-title":"Gut microbiota: implications in Parkinson's disease","volume":"38","author":"Parashar","year":"2017","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.bpg.2025.102060_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/cmi.2017.57","article-title":"Microbiota or short-chain fatty acids: which regulates diabetes?","volume":"15","author":"Kim","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bpg.2025.102060_bib7","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41564-019-0483-9","article-title":"Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC\/IBD diagnoses","volume":"4","author":"Vieira-Silva","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bpg.2025.102060_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies","volume":"56","author":"Seo","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.bpg.2025.102060_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","article-title":"The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy","volume":"33","author":"Gopalakrishnan","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bpg.2025.102060_bib10","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2025.102060_bib11","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.bpg.2025.102060_bib12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory Bowel Diseases (IBD) and the Microbiome\u2014Searching the crime scene for clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.102060_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00616-22","article-title":"Dysbiosis in the gut Microbiota in patients with inflammatory bowel disease during remission","volume":"10","author":"Pisani","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bpg.2025.102060_bib14","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/gutjnl-2023-329948","article-title":"The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease","volume":"72","author":"Lopetuso","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.102060_bib15","first-page":"15","article-title":"Personalized dietary regimens for inflammatory bowel disease: current knowledge and future perspectives","volume":"16","author":"Wellens","year":"2023","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.bpg.2025.102060_bib16","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3390\/biom11121903","article-title":"Prebiotics, probiotics, synbiotics, paraprobiotics and postbiotic compounds in IBD","volume":"11","author":"Martyniak","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bpg.2025.102060_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9999925","article-title":"Fecal Microbiota transplants for inflammatory bowel disease treatment: Synthetic- and engineered communities-based Microbiota transplants are the future","volume":"2022","author":"Khan","year":"2022","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.bpg.2025.102060_bib18","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/ibd\/izz298","article-title":"Antibiotic cocktail for pediatric acute severe colitis and the microbiome: the PRASCO randomized controlled trial","volume":"26","author":"Turner","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.102060_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/gutjnl-2022-327845","article-title":"Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study","volume":"72","author":"Faye","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.102060_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.102060_bib21","doi-asserted-by":"crossref","DOI":"10.4110\/in.2022.22.e44","article-title":"Microbial modulation in inflammatory bowel diseases","volume":"22","author":"Yu","year":"2022","journal-title":"Immune Netw"},{"key":"10.1016\/j.bpg.2025.102060_bib22","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1016\/j.clnu.2021.05.033","article-title":"Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: a pilot study investigating the potential for primary prevention of inflammatory bowel disease","volume":"40","author":"Hedin","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bpg.2025.102060_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103598","article-title":"Prebiotic galactooligosaccharide supplementation in adults with ulcerative colitis: exploring the impact on peripheral blood gene expression, Gut Microbiota, and clinical symptoms","volume":"13","author":"Wilson","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2025.102060_bib24","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.1039\/D1FO01147B","article-title":"Fructooligosaccharide supplementation alleviated the pathological immune response and prevented the impairment of intestinal barrier in DSS-induced acute colitis mice","volume":"12","author":"Liao","year":"2021","journal-title":"Food Funct"},{"key":"10.1016\/j.bpg.2025.102060_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000922","article-title":"Therapeutic and prebiotic effects of five different native starches on Dextran Sulfate Sodium-Induced mice model of colonic colitis","volume":"65","author":"Xu","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.bpg.2025.102060_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.639948","article-title":"A novel grape-derived prebiotic selectively enhances abundance and metabolic activity of butyrate-producing bacteria in faecal samples","volume":"12","author":"Oliver","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bpg.2025.102060_bib27","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1039\/D0FO00116C","article-title":"Tilapia head glycolipids reduce inflammation by regulating the gut microbiota in dextran sulphate sodium-induced colitis mice","volume":"11","author":"Gu","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.bpg.2025.102060_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/biomimetics4020032","article-title":"Interaction between Chitosan and mucin: fundamentals and applications","volume":"4","author":"Collado-Gonz\u00e1lez","year":"2019","journal-title":"Biomimetics"},{"key":"10.1016\/j.bpg.2025.102060_bib29","article-title":"Chitosan ameliorates DSS-induced ulcerative colitis mice by enhancing intestinal barrier function and improving microflora","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpg.2025.102060_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2022.12.013","article-title":"In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release","volume":"183","author":"Moutaharrik","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.bpg.2025.102060_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomimetics4020032","article-title":"Interaction between Chitosan and Mucin: fundamentals and applications","volume":"4","author":"Collado-Gonz\u00e1lez","year":"2019","journal-title":"Biomimetics"},{"key":"10.1016\/j.bpg.2025.102060_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119351","article-title":"Advances in the colon-targeted chitosan based multiunit drug delivery systems for the treatment of inflammatory bowel disease","volume":"288","author":"Kulkarni","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.bpg.2025.102060_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejps.2017.08.025","article-title":"Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease","volume":"109","author":"Helmy","year":"2017","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.bpg.2025.102060_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.actbio.2016.10.026","article-title":"Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis","volume":"48","author":"Xu","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.bpg.2025.102060_bib35","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.058","article-title":"Probiotics: promise, evidence, and hope","author":"Khoruts","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.102060_bib36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.102060_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2022.102652","article-title":"Role of a probiotic strain in the modulation of gut microbiota and cytokines in inflammatory bowel disease","volume":"78","author":"Bamola","year":"2022","journal-title":"Anaerobe"},{"key":"10.1016\/j.bpg.2025.102060_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae095","article-title":"Probiotic Treatment of Ulcerative Colitis with Trichuris Suis Ova: A Randomised, Double-blinded, Placebo-controlled Clinical Trial [the PROCTO Trial]","volume":"18","author":"Prosberg","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.102060_bib39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease","volume":"27","author":"Bjarnason","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bpg.2025.102060_bib40","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jafc.2c07098","article-title":"Oral delivery of Mouse \u03b2-Defensin 14 (mBD14)-Producing Lactococcus lactis NZ9000 attenuates experimental colitis in mice","volume":"71","author":"Tian","year":"2023","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bpg.2025.102060_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izac238","article-title":"Vitamin D3 and Lactobacillus rhamnosus GG\/p40 synergize to protect mice from colitis by promoting vitamin D receptor expression and epithelial proliferation","volume":"29","author":"Chen","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.102060_bib42","doi-asserted-by":"crossref","DOI":"10.1007\/s42770-023-00928-0","article-title":"Immunomodulatory effects of different strains of Lactococcus lactis in DSS-induced colitis","author":"Alves","year":"2023","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.bpg.2025.102060_bib43","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1007\/s00253-019-10094-9","article-title":"Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice","volume":"103","author":"Wang","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.bpg.2025.102060_bib44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/foods12040897","article-title":"Protective effect of Lactiplantibacillus plantarum subsp. plantarum SC-5 on Dextran Sulfate Sodium\u2014Induced colitis in mice","volume":"12","author":"Shi","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.bpg.2025.102060_bib45","article-title":"Coprococcus eutactus , a potent probiotic, alleviates Colitis via acetate-mediated IgA response and Microbiota restoration","author":"Yang","year":"2023","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bpg.2025.102060_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1089600","article-title":"The role of Akkermansia muciniphila in inflammatory bowel disease: current knowledge and perspectives","volume":"13","author":"Zheng","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpg.2025.102060_bib47","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1039\/D2FO01577C","article-title":"Strains producing different short-chain fatty acids alleviate DSS-induced ulcerative colitis by regulating intestinal microecology","volume":"13","author":"Yang","year":"2022","journal-title":"Food Funct"},{"key":"10.1016\/j.bpg.2025.102060_bib48","doi-asserted-by":"crossref","first-page":"i243","DOI":"10.1093\/ecco-jcc\/jjac190.0209","article-title":"P079 Attenuation of inflammation and histologic production-dependent improvement by engineered high acetate producing Saccharomyces boulardii in DSS-induced colitis","volume":"17","author":"Deleu","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.102060_bib49","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1136\/gutjnl-2021-325413","article-title":"Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists","volume":"71","author":"Huo","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.102060_bib50","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201702","article-title":"Tannins amount determines whether tannase-containing bacteria are probiotic or pathogenic in IBD","volume":"6","author":"He","year":"2023","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.bpg.2025.102060_bib51","article-title":"Are heat-killed probiotics more effective than live ones on colon length shortness, disease activity index, and the histological score of an inflammatory bowel disease-induced murine model? A meta-analysis","volume":"134","author":"Poaty Ditengou","year":"2023","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.bpg.2025.102060_bib52","article-title":"Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis","author":"Zhang","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.bpg.2025.102060_bib53","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1007\/s00394-020-02200-9","article-title":"Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases","volume":"59","author":"Shinde","year":"2020","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.bpg.2025.102060_bib54","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3390\/nu12082380","article-title":"Modulating the microbiome and immune responses using whole plant fibre in synbiotic combination with fibre-digesting probiotic attenuates chronic colonic inflammation in spontaneous colitic mice model of IBD","volume":"12","author":"Shinde","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2025.102060_bib55","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1039\/C9FO02992C","article-title":"Study of the alleviation effects of a combination of Lactobacillus rhamnosus and inulin on mice with colitis","volume":"11","author":"Liu","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.bpg.2025.102060_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123326","article-title":"A synbiotic combination of Bifidobacterium longum Bif10 and Bifidobacterium breve Bif11, isomaltooligosaccharides and finger millet arabinoxylan prevents dextran sodium sulphate induced ulcerative colitis in mice","volume":"231","author":"Sharma","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bpg.2025.102060_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5152\/tjg.2019.18356","article-title":"Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: a randomized placebo-controlled study","volume":"30","author":"Kamarli Altun","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.102060_bib58","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.3390\/jcm10214961","article-title":"Efficacy of a preparation based on calcium butyrate, Bifidobacterium bifidum, Bifidobacterium lactis, and fructooligosaccharides in the prevention of relapse in ulcerative colitis: a prospective observational Study","volume":"10","author":"Caviglia","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.bpg.2025.102060_bib59","first-page":"1","article-title":"Use of synbiotics for ulcerative colitis treatment","volume":"15","author":"Roselli","year":"2019","journal-title":"Curr Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.bpg.2025.102060_bib60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.102060_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ebiom.2021.103293","article-title":"Short chain fatty acids and its producing organisms : an overlooked therapy for IBD","volume":"66","author":"Deleu","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bpg.2025.102060_bib62","article-title":"Short chain fatty acids (SCFAs)mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpg.2025.102060_bib63","article-title":"Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease","volume":"32","author":"Facchin","year":"2020","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.bpg.2025.102060_bib64","article-title":"Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes","volume":"33","author":"Sitkin","year":"2021","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.bpg.2025.102060_bib65","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/ijms24010768","article-title":"High acetate concentration protects intestinal barrier and exerts anti-inflammatory effects in organoid-derived epithelial monolayer cultures from patients with ulcerative colitis","volume":"24","author":"Deleu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpg.2025.102060_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.102060_bib67","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gutjnl-2022-327337","article-title":"Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases","volume":"72","author":"Michaudel","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.102060_bib68","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2022.07.052","article-title":"Effect of 5-Hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial","volume":"163","author":"Truyens","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.102060_bib69","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.actbio.2023.02.026","article-title":"ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease","volume":"161","author":"Bao","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.bpg.2025.102060_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.777147","article-title":"Effect of extracellular vesicles derived from Lactobacillus plantarum Q7 on Gut Microbiota and ulcerative colitis in mice","volume":"12","author":"Hao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpg.2025.102060_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.551449","article-title":"Inhibitory effects of the Lactobacillus rhamnosus GG effector protein HM0539 on inflammatory response through the TLR4\/MyD88\/NF-\u043aB axis","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpg.2025.102060_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1052644","article-title":"Postbiotic muramyl dipeptide alleviates colitis via activating autophagy in intestinal epithelial cells","volume":"13","author":"You","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bpg.2025.102060_bib73","first-page":"569","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017"},{"key":"10.1016\/j.bpg.2025.102060_bib74","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5694\/mja17.00295","article-title":"Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials","volume":"207","author":"Moayyedi","year":"2017","journal-title":"Med J Aust"},{"key":"10.1016\/j.bpg.2025.102060_bib75","first-page":"156","article-title":"Effect of fecal microbiota transplantation on 8-Week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019"},{"key":"10.1016\/j.bpg.2025.102060_bib76","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2025.102060_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132753","article-title":"Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitis\u2014results of a randomized controlled trial","volume":"10","author":"B\u0159ezina","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.bpg.2025.102060_bib78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.102060_bib79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.102060_bib80","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial","volume":"71","author":"Kedia","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.102060_bib81","first-page":"1","article-title":"Guidance for fecal microbiota transplantation trials in ulcerative colitis: the second ROME consensus conference","volume":"XX","author":"Lopetuso","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.102060_bib82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00384-023-04354-4","article-title":"Fecal microbiota transplantation for induction of remission in Crohn's disease: a systematic review and meta-analysis","volume":"38","author":"Zhou","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.bpg.2025.102060_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15265161.2017.1299240","article-title":"Ethical issues in fecal microbiota transplantation in practice","volume":"17","author":"Ma","year":"2017","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.bpg.2025.102060_bib84","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ismej.2009.112","article-title":"Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice","volume":"4","author":"Zhang","year":"2010","journal-title":"ISME J"},{"key":"10.1016\/j.bpg.2025.102060_bib85","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2025.102060_bib86","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","article-title":"Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome","volume":"70","author":"Bolte","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.102060_bib87","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/gutjnl-2019-319505","article-title":"Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies","volume":"69","author":"Khalili","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.102060_bib88","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/jn\/nxaa386","article-title":"Replacing animal protein with soy-pea protein in an \u201cAmerican Diet\u201d controls Murine Crohn disease-like ileitis regardless of firmicutes: bacteroidetes ratio","volume":"151","author":"Raffner","year":"2021","journal-title":"J Nutr"},{"key":"10.1016\/j.bpg.2025.102060_bib89","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/nu13030832","article-title":"Let food be thy Medicine\u2014Its role in Crohn's disease","volume":"13","author":"Wellens","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2025.102060_bib90","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2046244","article-title":"Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: pilot study","volume":"14","author":"Olendzki","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bpg.2025.102060_bib91","doi-asserted-by":"crossref","DOI":"10.1080\/00365521.2024.2423828","article-title":"Effects of an anti-inflammatory diet (AID) on maternal and neonatal health outcomes in pregnant Chinese patients with inflammatory bowel disease treated with infliximab (IFX)","volume":"59","author":"Ye","year":"2024","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.102060_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/nu13113736","article-title":"A novel uc exclusion diet and antibiotics for treatment of mild to moderate pediatric ulcerative colitis: a prospective open-label pilot study","volume":"13","author":"Sarbagili-Shabat","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2025.102060_bib93","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2020.05.026","article-title":"Low-Fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis","volume":"19","author":"Fritsch","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.102060_bib94","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review","volume":"166","author":"Hashash","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.102060_bib95","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.3390\/nu16234201","article-title":"The key nutrients in the Mediterranean diet and their effects in inflammatory bowel disease: a narrative review","volume":"16","author":"Deleu","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.bpg.2025.102060_bib96","article-title":"Effects of kefir fermented milk beverage on sodium dextran sulfate (DSS)-induced colitis in rats","volume":"9","author":"Nascimento da Silva","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bpg.2025.102060_bib97","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5152\/tjg.2018.18227","article-title":"Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial","volume":"30","author":"Y\u0131lmaz","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.102060_bib98","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjab165","article-title":"Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the CRAFT UC randomised controlled trial","volume":"16","author":"Shabat","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.102060_bib99","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1554","article-title":"Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study","author":"Narula","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.bpg.2025.102060_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1058373","article-title":"Ultra-processed foods as a possible culprit for the rising prevalence of inflammatory bowel diseases","volume":"9","author":"Vissers","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.bpg.2025.102060_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/s41430-024-01487-9","article-title":"A pilot randomized controlled trial investigating the effects of an anti-inflammatory dietary pattern on disease activity, symptoms and microbiota profile in adults with inflammatory bowel disease","volume":"78","author":"Marsh","year":"2024","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.bpg.2025.102060_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/apt.70041","article-title":"Clinical trial: the effects of emulsifiers in the food supply on disease activity in Crohn's disease: an exploratory double-blinded randomised feeding trial","volume":"61","author":"Fitzpatrick","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2025.102060_bib103","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1249\/MSS.0000000000002112","article-title":"Exercise training modulates gut microbiota profile and improves endotoxemia","volume":"52","author":"Motiani","year":"2020","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.bpg.2025.102060_bib104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12876-019-0952-x","article-title":"Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial","volume":"19","author":"Cronin","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.bpg.2025.102060_bib105","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/2050640620936383","article-title":"Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease","volume":"8","author":"Seeger","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.bpg.2025.102060_bib106","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000371795","article-title":"The impact of a Ten-Week Physical Exercise Program on health-related quality of life in patients with inflammatory bowel disease: a prospective randomized controlled trial","volume":"91","author":"Klare","year":"2015","journal-title":"Digestion"},{"key":"10.1016\/j.bpg.2025.102060_bib107","article-title":"Exercise, gut microbiome, and gastrointestinal diseases: therapeutic impact and molecular mechanisms","volume":"0","author":"Hawley","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.102060_bib108","first-page":"84","article-title":"Exercise and immune system as modulators of intestinal microbiome: implications for the gut-muscle axis hypothesis","volume":"25","author":"Ticinesi","year":"2019","journal-title":"Exerc Immunol Rev"},{"key":"10.1016\/j.bpg.2025.102060_bib109","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3748\/wjg.v28.i8.878","article-title":"\u201cRole of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease\u201d: a letter to the editor","volume":"28","author":"Gettigan","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.102060_bib110","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/jcm14051708","article-title":"Physical exercise as a therapeutic approach in gastrointestinal diseases","volume":"14","author":"Severo","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.bpg.2025.102060_bib111","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/v15010173","article-title":"The emerging role of the gut virome in health and inflammatory bowel disease: challenges, covariates and a viral imbalance","volume":"15","author":"Jansen","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bpg.2025.102060_bib112","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izab343","article-title":"The neglected gut microbiome: Fungi, protozoa, and bacteriophages in inflammatory bowel disease","author":"Guzzo","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.102060_bib113","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.3748\/wjg.v30.i36.4078","article-title":"Beyond bacteria: role of non-bacterial gut microbiota species in inflammatory bowel disease and colorectal cancer progression","volume":"30","author":"Haque","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.102060_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1611","article-title":"Gut mycobiome: a \u201cblack box\u201d of gut microbiome\u2013host interactions","author":"Zhao","year":"2023","journal-title":"WIREs Mechanisms of Disease"},{"key":"10.1016\/j.bpg.2025.102060_bib115","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","article-title":"Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation","volume":"185","author":"Federici","year":"2022","journal-title":"Cell"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:48:03Z","timestamp":1768394883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691825000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":115,"alternative-id":["S1521691825000873"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2025.102060","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutting edge developments and novel targets in IBD: Microbiome in IBD","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2025.102060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102060"}}